Investment

Features

Pro Tools for Pro Traders

Uncover the powerful trading features

Pro Features

Pluang Web Trading

Leverage

Built for Investors

Experience investing with simplified features

Pockets

Recurring Buy

USD Yield

Pluang Cuan

Fees

Safety

Academy

Latest for You

Get up-to-date financial news and investing tips & information

Blog

Find various tips & information to become a knowledgeable investor

News and Analysis

Read the latest information about finance and investment

Learn

Become a smarter investor by learning the basics of investing

Glossary

Learn investment terms to understand investing better

Promo & Referral

Discover exclusive opportunities to level up your investments

Investment Clubs (Coming Soon)

Join hands with like-minded investors to grow wealth together

Press (Coming Soon)

Stay updated with our latest news and media coverage

Support

About Us

Contact

Ask

Career

Tax Reporting Guide

Pluang+

AbbVie Inc (ABBV) Stock Price Today

Overview

Financial

Technicals

Analysis

Corporate Action

About

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Technical Indicators

Overall Summary

Bearish (16)

Neutral (5)

Bullish (6)

Performance

ABBV ROI

+26.83%

% from 52W High

-3.22%

$192.94

52W Low: $137.6

15 Nov 2023

52W High: $199.35

10 Sep 2024

News

Globe Newswire

Bipolar Disorder Market Size to Reach USD 7 Billion by 2033, Says The Brainy Insights

The Motley Fool

Is This Company Still a Strong Buy After Tripling the S&P 500's Returns?

Globe Newswire

Global Buccal Drug Delivery Systems Market Research 2024-2030 Featuring Johnson & Johnson, Pfizer, Sanofi, Novartis, Bayer, Teva Pharmaceuticals, AbbVie, Cipla, and Haleon

Benzinga

Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies

The Motley Fool

3 Things You Need to Know if You Buy AbbVie Stock Today

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions